TYMP and neoplasm: The favourable results obtained from treatment with capecitabine in combination with low-dose cisplatin may be explained mainly by its tumour specificity as determined by thymidine phosphorylase (TP), which is expressed at higher levels in tumour tissue compared to normal tissue (23).